860-P: Users with Type 2 Diabetes Using a Digital Platform Experienced Sustained Improvement in Blood Glucose Levels
| Autor: | Yifat Hershcovitz, Sharon Dar, Eitan Feniger |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Change over time
education.field_of_study medicine.medical_specialty business.industry Endocrinology Diabetes and Metabolism Population Type 2 diabetes medicine.disease Retrospective data Diabetes mellitus Internal Medicine High Readings Physical therapy Medicine Observational study Prediabetes business education |
| Zdroj: | Diabetes. 69 |
| ISSN: | 1939-327X 0012-1797 |
| DOI: | 10.2337/db20-860-p |
| Popis: | Introduction: Reduction of high readings and maintaining blood glucose target levels (fasting and post-meal) are great challenges in managing diabetes. Digital engagement can play a key role in enhancing patient understanding of their condition and helping them make better decisions regarding their actual situation. The Dario platform allows for real time evaluation of blood glucose levels change over time and for a precise intervention based on actual behavioral and clinical indicators. Method: A retrospective data evaluation (Q1:2018-2019) was performed on the Dario® data base. A population of active users (18 measurements per month with the Dario® System on average) with type 2 diabetes (T2D), non-Insulin treated was evaluated over a full year. High blood glucose readings (180-400 mg/dL, >250 mg/dL), fasting readings ( Results: For 9,200 users with T2D, non-Insulin users, the average ratio of high glycemia events (180-400 mg/dL) from entire set of measurements was reduced by 26% (18.62% vs. 23.43%) while readings of >250mg/dL were reduced by 33% (4.65% vs. 6.93%) over a year. Fasting measurements analysis revealed an increase of 16% in ratios of readings Conclusion: Digital diabetes platform results in a large population are consistent with previous studies and show the potential to promote behavior modification in users with T2D. The study demonstrates that digital management platform may assist user to better control their blood glucose levels and sustain behavioral change. This observational data presents an improvement in high glycemia readings ratios, and an increase in prediabetes fasting blood glucose levels sustained over one year. Disclosure Y. Hershcovitz: Employee; Self; DarioHealth. S. Dar: Employee; Self; DarioHealth. E. Feniger: Employee; Self; DarioHealth. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|